The researchers, led by Christopher Grunseich (National Institutes of Health, Bethesda, Maryland, USA), note in The Lancet Neurology that there was ... read more
Positive initial results for IGF-1 pathway as treatment target in spinal and bulbar muscular atrophy
Positive initial results for IGF-1 pathway as treatment target in spinal and bulbar muscular atrophy